CO-RAMICOR 2,5 MG/12,5 MG tablett Естония - естонски - Ravimiamet

co-ramicor 2,5 mg/12,5 mg tablett

hexal ag - ramipriil+hüdroklorotiasiid - tablett - 2,5mg+12,5mg 30tk; 2,5mg+12,5mg 60tk; 2,5mg+12,5mg 100tk

APYDAN 300 MG tablett Естония - естонски - Ravimiamet

apydan 300 mg tablett

desitin arzneimittel gmbh - okskarbasepiin - tablett - 300mg 50tk; 300mg 100tk

CARBALEX 400 MG tablett Естония - естонски - Ravimiamet

carbalex 400 mg tablett

g.l. pharma gmbh - karbamasepiin - tablett - 400mg 50tk

Firdapse (previously Zenas) Европейски съюз - естонски - EMA (European Medicines Agency)

firdapse (previously zenas)

serb sa - amifampridiin - lambert-eaton müasteense sündroom - muud närvisüsteemi ravimid - lambert-eatoni myasteniidi sündroomi (lems) sümptomaatiline ravi täiskasvanutel.

Galvus Европейски съюз - естонски - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptiin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Jalra Европейски съюз - естонски - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptiin - suhkurtõbi, tüüp 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

Xiliarx Европейски съюз - естонски - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptiin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

Zalviso Европейски съюз - естонски - EMA (European Medicines Agency)

zalviso

fgk representative service gmbh - sufentaniil - valu, postoperatiivne - anesteetikumid - zalviso on näidustatud ägeda mõõduka kuni raske operatsioonijärgse valu raviks täiskasvanud.

Dzuveo Европейски съюз - естонски - EMA (European Medicines Agency)

dzuveo

laboratoire aguettant - sufentanil citrate - valu - anesteetikumid - dzuveo is indicated for the management of acute moderate to severe pain in adult patients.

TRIFAS COR tablett Естония - естонски - Ravimiamet

trifas cor tablett

menarini international operations luxembourg s.a. - torasemiid - tablett - 5mg 100tk; 5mg 30tk; 5mg 50tk